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Available online 11 May 2017In this work a set of novel materials for bone tissue regeneration have been tested in vivo in an animal model. In
fact, despitemany studies havebeendevoted to amorphous 45S5Bioglass®, there is lack in the literature ofworks
aimed to study the in vivo performance of heat-treated – and thus partially crystallized – 45S5. Aswidely report-
ed, crystallization limits the bioactivity of 45S5 and is themain reason that prevents a broader use of thismaterial.
Thus, in the present work, a recently developed bioactive glass (BG_Ca/Mix) is tested, since previous investiga-
tions demonstrated that BG_Ca/Mix is particularly promising by virtue of both its high bioactivity and lower ten-
dency to crystallize with respect to 45S5. BG_Ca/Mix sintered powders and two composites, which contain
BG_Ca/Mix and an increasing percentage (20 wt% or 70 wt%) of hydroxyapatite (HA), were considered. As a
term of comparison, 45S5 sintered powders were also studied. The samples were implanted in rabbits' femurs
and harvested after 8weeks. The histological analysis demonstrated that BG_Ca/Mix has an osteoconductive abil-
ity slightly higher than that of 45S5 glass-ceramics, followed by that of the composites, whichmay represent the
starting point for obtaining systems with degradation rate tailored for a given clinical application. Moreover, the
45S5 samples were locally cracked, probably because of a non-uniform dissolution in the physiological environ-
ment. On the contrary such cracks, which could lead to implant instability and unsuitable mechanical perfor-
mance, were not observed in BG_Ca/Mix.






The biomaterials ﬁeld has grown signiﬁcantly over the last 50 years,
evolving through three different generations: biointert materials (ﬁrst
generation), bioactive and biodegradablematerials (second generation)
and, ﬁnally, materials designed to induce appropriate responses at the
molecular level (third generation) [1]. Recent developments include hy-
brid and inorganic materials for delivery, therapy, sensors, etc. [2–5];
nanoparticles for drug and gene delivery [6–8], metal nanostructures
for photothermal therapy [9,10], systemswith antibacterial and anti-in-
ﬂammatory properties [8,11,12], functionally gradedmaterials [13], ad-
vanced bio-coatings [14–15], tissue and bone substitutes [16,17]. In this
context, the pathologies associatedwith themusculoskeletal system in-
volve hundreds of millions of people all over the world. The need for
new surgical materials to treat musculoskeletal inﬁrmities and, in partic-
ular, bone loss due to cancer, trauma, osteoporosis and jaw atrophies, has
focused the interest of materials' scientists on calcium phosphate ce-
ramics (CPs), which currently play a fundamental role in orthopaedics,ing “E. Ferrari”, University of
ena, Italy.
.hand surgery, maxillofacial and oral surgery [18,19]. In fact, thanks to
their high biocompatibility, CPs are ideal candidates for the realization
of prostheses, orthopaedic devices and synthetic bone grafts. Among
CPs, hydroxyapatite (HA) is probably the most widely used material, by
virtue of its close crystal and chemical resemblance to the inorganic com-
ponent of biological hard tissues (i.e., bone and teeth). In fact, HA is highly
osteoconductive and it is able to forma strongbondwith the surrounding
living bone [20].
Bioactive glasses are an attractive alternative to HA, as they are typ-
ically able to bond to bone more rapidly than other bioceramics. 45S5
Bioglass® [21], a degradable glass in the Na2O–CaO–SiO2–P2O5 system,
was the ﬁrst bioactive glass discovered. Bioactive glasses have unique
properties, if compared to CPs and HA. In addition to their high reactiv-
ity in vivo, in vitro studies reported that the ions released during the
45S5 Bioglass® dissolution (e.g. Si, P, Ca) seem to induce angiogenesis,
neo vascularisation and stimulate osteoblasts proliferation and new
bone growth [22]. Moreover, certain compositions of bioactive glasses
are able to bond to both bone and soft connective tissues [23].
Probably, the main disadvantage of Bioglass® and, in general, of bio-
active glasses, is their tendency to crystallize during the heat treatments
which are necessary for the production of special products, such as scaf-
folds, coatings and composites with CPs as second phase. In fact,
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these reasons, the investigation of new bioactive glasses with low ten-
dency to devitriﬁcation, to be used whenever a heat treatment is neces-
sary, is particularly important. Among such novel compositions, the so-
called BG_Ca/Mix (47.3 mol% SiO2, 45.6 mol% CaO, 2.3 mol% K2O,
2.3 mol% Na2O, and 2.6 mol% P2O5) [25,26], which has been developed
in recent years, looks particularly promising: while a crystallization tem-
perature of about 650 °C is reported for Bioglass® [27], BG_Ca/Mix starts
to crystallize at temperatures as high as 880 °C. Moreover, BG_Ca/Mix is
characterized by a slower ion leaching in physiological solution with re-
spect to Bioglass®, thus determining pH values which can be considered
optimal for cell adhesion, proliferation and differentiation [25].
In previous works, BG_Ca/Mix has been successfully used to deposit
coatings and, in particular, for the realization of HA-based composites
containing up to 80 wt% of glass [28–30]. The production of HA/bioac-
tive glass composites is especially interesting, as it is possible to over-
come the intrinsic limits of the glassy and the ceramic phases when
considered singularly. Themain objective is to tailor the biodegradation
rate and the bioactivity of the resulting system by varying the volume
fractions of the two constituents. Moreover, the use of bioactive glasses
can be exploited to incorporate ions of biological interest within HA lat-
tice, such as silicon, strontium,magnesium, etc., in order to simulate the
behaviour of the so-called biological apatite, i.e. the mineral part of
bone, which is typically nonstoichiometric and characterized by several
ionic substitutions [18,31]. Thanks to the peculiarities of BG_Ca/Mix, it
was possible to sinter the HA-based composites at lower temperatures
with respect to samples with the same HA/Bioglass® ratio, thus reduc-
ing the crystallization of the glassy phase and avoiding the decomposi-
tion of HA and/or reactions between HA and glass. The in vitro
biocompatibility of both BG_Ca-Mix and of HA/BG_Ca-Mix composites
has been successfully proved in recent investigations [28,32].
In the presentwork, for theﬁrst time, the novel BG_Ca/Mix (sintered
powders) and the HA/BG_Ca-Mix composites have been tested in vivo
in an animal model. The samples were implanted bilaterally in the
midshafts rabbit femurs and harvested after 8 weeks. Two composites
with an increasing content of HA were considered. It should be noted
that, although the literature reports several studies dealing with HA-
based composites with phosphate bioglasses as second phase, only in
the last years silicate glasses, such as Bioglass®, have been employed
in combination with HA to realize biocomposites, by virtue of their
osteoinductivity. Therefore, in the literature, there is lack of investiga-
tions dealing with these systems and based on animal models. Further-
more, in this work also 45S5 sintered powders were implanted and
considered as a term of comparison. In fact, the in vivo behaviour of
45S5-derived glass ceramics is fundamental in order to evaluate the fea-
sibility of speciﬁc implants, such as 45S5 scaffolds, whose production
may require the consolidation of glass powders. Although in the last
40 years innumerable studies have been devoted to amorphous 45S5
[24,33], only in recent years the efforts of several researches have
been addressed to understand the connections between sintering, crys-
tallization and in vivo bioactivity of heat-treated 45S5.
2. Materials and methods
2.1. Bioactive glasses and composites preparation
Bioactive glass powders were produced by melting the commercial
raw materials (SiO2, Ca3(PO4)2, CaCO3, Na2CO3, all reagent grade -
Carlo Erba Reagenti, Italy; to prepare BG_Ca/Mix, part of Na2CO3 has
been replaced by K2CO3) in Pt crucibles at 1450 °C. The following ther-
mal cycle was employed: from room temperature to 1100 °C at 10 °C/
min; an isothermal step at 1100 °C for 1 h to allow decarbonation;
from 1100 °C to 1450 °C at 10 °C/min. The molten glasses were
quenched into water to obtain two frits, which have been left to dry in
an oven at 110 °C for 24 h. The 45S5 and BG_Ca/Mix frits have been sub-
sequently crushed in dry conditions in a porcelain jar and ﬁnally sievedto obtain a powder (grain size b67 μm). Subsequently, 45S5 and BG_Ca/
Mix powders were wetted with acetone and pressed to produce green
bodies. As previously reported in refs [25,34], 45S5 and BG_Ca/Mix
green bodies were sintered for 3 h at 1050 °C and 800 °C, respectively.
A heating rate of 10 °C/min was used for both glasses. At the end of
the thermal treatments the samples have been extracted from the
oven and left to cool down at room temperature.
The BG_Ca/Mix glass powders were mixed with commercial HA
powders (CAPTAL® Hydroxylapatite, Plasma Biotal Ltd., UK) for 6 h in
a polyethylene bottle using a roll shaker to obtain the following set of
composites:
• 80 wt% BG_Ca/Mix and 20 wt% HA powders (“80BG20HA”);
• 30 wt% BG_Ca/Mix and 70 wt% HA powders (“30BG70HA”).
80BG20HA and 30BG70HA powders were then wetted with acetone
and pressed to produce the green bodies, which have been heat-treated
for 3 h at 830 °C and 900 °C, respectively, as reported in previous works
[28]. Finally, the fully dense bodies (45S5, BG_Ca/Mix and composites)
were abraded to obtain samples in form of prismatic rods (~6 × 2
× 2 mm), which were subsequently sterilized in ethylene oxide before
implantation.
2.2. Animals and surgery
Eight healthy six-months-old white New Zealand rabbits (Harlan
Laboratories S.r.l., Correzzana, Monza e Brianza, Italy) with an average
body weight of 5 kg were used. The animals were maintained for accli-
mation to housing conditionswith food andwater ad libitum at least for
one week before surgery. The night before surgery, each animal was
fasted to be ready for anesthesia. The experiments were carried out ac-
cording to the Bioethical Committee of the Italian National Institute of
Health and authorized with Decrees of the Italian Ministry of Health
(Protocol Number: 210/2013-B). Animal care, maintenance, and sur-
gery were conducted in accordance with Italian law (D.L. no. 26/2014)
and European legislation (EEC no. 63/2010).
The animals were weighed and submitted to the same surgical pro-
cedure under general anesthesia with a mixture of xylazine (4 mg/kg
body weight) (Sedaxylan®, Dechra Veterinary Products S.r.l., Turin,
Italy) and ketamine (30 mg/kg body weight) (Imalgene 1000®, Merial
Italia S.p.A., Milan, Italy). If necessary, further sedation was obtained
by means of propofol (7 mg/kg) (Propovet®, Ecuphar S.r.l., Piacenza,
Italy) administrated in the marginal ear vein.
After induction of anesthesia, shaving and antisepsis were carried
out on the legs to be operated. A 3 cm long skin incision was made on
the antero-lateral surface of the tight; after blunt dissection of muscles,
the proximal diaphysis of the femur was reached. An incision was
made on the periosteum by a scalpel to expose the femur cortex. Two
cortical holes of 3.5mm in diameter and 7mm in depth in themidshafts
rabbit femur were bilaterally drilled under continuous saline irrigation,
using a bone trepan bur (227B.204.040; Komet Italia S.r.l., Milan, Italy;
motor system and drilling procedure: run at a speed of 1700 rpm,
Physiodispenser 7000, Nouvag AG; Switzerland).
Three rods of different bioactive glass/composite and one sham
(without implant)were placed in the left and right femur of each rabbit,
as shown Fig. 1. The shape of the samples allowed them to remain stuck
in the drilled cylindrical hole, applying the stabilization criterion needed
in the bone grafting procedure [35–37]. Sham holes remained empty as
controls, with the aim of evaluating the spontaneous bone healing
(Fig. 1(c)). The fascia-periosteal ﬂaps were sutured by 4.0 glycolide/L-
lactide copolymer (Vicryl®, Ethicon, Johnson & Johnson, Livingston,
UK) and the skin with 3.0 silk (Perma-hand® Silk Suture, Ethicon, John-
son & Johnson, Livingston, UK).
Post-operatively, single intramuscular injections of antibiotics
(enroﬂoxacin, 10 mg/kg body weight) (Baytril 5%®, 50 mg/ml, Bayer
S.p.A., Milan, Italy) and analgesic (buprenorphine, 0.05 mg/kg body
Fig. 1. Intra-operative pictures of hole drilling in rabbitmidshaft (a, b). Bioceramic rodswerepositioned in theholes as shown in (c); in particular, the diagram reported in (c) described the
proximal and distal anatomic orientation of the rabbit left femur: the sample 1 is more proximally placed compared to the sample 2. A micro-radiography performed on a postharvest
rabbit femur is shown in (d).
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animalswere housedwith veterinary care and nutritional support in in-
dividual cages during the whole experimental period.2.3. Samples' preparation and micro-radiography
The animalswere sacriﬁced 60 days after surgical osteotomywith an
intravenous injection of embutramide plus mebezonium iodide
(0,3 ml/kg body weight) (Tanax® 50mg, MSD Animal Health S.r.l. Italia,
Segrate, Milan, Italy), under general anesthesia with a mixture of
xylazine (4 mg/kg body weight) (Sedaxylan®, Dechra Veterinary Prod-
ucts Srl, Turin, Italy) and ketamine (30 mg/kg body weight) (Imalgene
1000®, Merial Italia SpA, Milan, Italy). The right and left femurs were
disarticulated from the hip joint and the knee.Fig. 2. Intraoperative view of the bioceramics specimens immediately after implantation (a–d
stabilitation required for osteointegration. Cross-sectional micro-Rx of rabbit femurs in the siteSoft tissuewas removed from the femurs by a dissector. Then, the fe-
murs were put in formalin solution (10% buffered) at 4 °C for 24 h. For
histological preparation the specimens were washed for 1 h at 4 °C in
0.1 M phosphate buffer pH 7.2.
X-ray imagingwas performed on ﬁxed femurs employing IVIS Lumi-
na XMRS® imaging system (Perkin Elmer Italia S.p.A., Milan, Italy), used
at low-energy (1–3 milligray (mGy) high-resolution (see Fig. 2).
The femurs were dehydrated through an ascendant scale of ethyl al-
cohol, (70°, 80°, 90°, 99° and pure alcohol), treated for 10 h in a 1:1 pure
alcohol/MMA (methylmetacrylate) moisture and then for one night in
MMA only. Filtering solution was added for 24 h with 3 consecutive
changes, then the samples were moved into a ﬂatted bottom polyethyl-
ene container with the hermetically closed polymerizing solution and
embedded in MMA. The container was maintained in a water bath at
4 °C during the MMA polymerization process. After polymerization,). Thanks to hole calibration related to speciﬁc rods' dimension, all samples achieved the
of rods' implantation, acquired after harvesting, are reported in (e–f).
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(REMET, Bologna, Italy).
Sections from the femur with implanted material were micro-
radiographed, with a intraoral X-Ray digital imaging device (VarioDG;
Sirona Dental Systems S.r.l., Verona, Italy). The sections were cut to a
thickness of 60–80–100 μm using diamond lap disk (LS2 Remet, Bolo-
gna, Italy) for histological dye and micro-radiography; a further set of
thicker sections (500 μm) were prepared for observation in a scanning
electron microscope (SEM, see next paragraph).
2.4. Histological analysis
The sectionswere stained in Stevenel's blue and counterstainedwith
Van Gieson trichromic stain picro-fuchsin pro light microscopy. Sam-
ples preparation was speciﬁcally carried out by immersion in Stevenel's
blue stain, in awater bath at 60 °C for 10min, followed by rinsing in dis-
tilledwater. Subsequently, the specimenswere put in VanGieson picro-
fuchsin for 5min at room temperature and then immersed in ﬁnal rinse
ethanol 100%. Poly-mount xylene was used for mounting. Finally, the
following staining was obtained: purple/red to orange for mineralized
bone, and shades of blue and green for non-mineralized osteoid [38,39].
The sections were observed and analyzed in a light microscope
(Nikon Eclipse 80, NIKON, Tokyo, Japan) connected to a personal com-
puter with a software for morphometry (Nikon DS Fi1, Nikon, Tokyo,
Japan). During the observation, particular attentionwas given to the in-
terface between implant and bone, with the aim of determining the na-
ture of the bone–implant interface and of searching for an eventual
evidence of ﬁbrous encapsulation, inﬂammatory reaction and bone
contact.
500 μm thick sections were investigated by means of a SEM (ESEM
Quanta 200, FEI Co., Eindhoven, The Netherland). The specimens were
gold coated before observation. Local chemical analyses were carried
out by X-ray energy dispersion spectroscopy, EDS (Inca, Oxford Instru-
ments, UK).
3. Results
3.1. Comments on surgery
One animal was sacriﬁced after 1 week of implantation because of
fracture of one leg, probably due to the high weight of the animal itself.
No complications were observed in the remaining animals. The sites of
implantation appeared to be healedwith no visible signs of infection, in-
ﬂammation or adverse tissue reaction. Post-harvest radiographs were
taken to conﬁrm that the implants had been placed successfully, i.e.
penetrating the cortex into the medullary canal of the femur, prior to
gross reduction of the specimens. The sham-operated samples were
not processed either for scanning electron or light microscopy.
3.2. Microradiography
An intraoperative view of the specimens during and immediately
after implantation is shown in Figs. 1 and 2(a–d). All samples achieved
the adequate stabilization required for osteointegration. Postoperative
microradiographs reported in Fig. 2(e–h) showed that the implanted
rodswere completely incorporated in the femurmid-shafts. The cortical
bone layer healed over the implanted rods, covering them almost
completely in all samples. Moreover, newly formed bone was present
at the edge of the implants that overhanged in the marrow cavity,
thus forming bone bridges that connect the implanted rods to the
inner surface of medullary canal. In particular, all around the surface
in the marrow cavity, the 45S5 rod showed a ﬁne isodenser layer com-
pared to native femur bone (Fig. 2(e)). The subsequent SEM analysis
allowed to identify such layer as newly formed bone (see the following
paragraphs). Also the BG_Ca/Mix rod, whose section has a triangular
shape (Fig. 2(f)), was surrounded by a ﬁne isodense layer and a bridgeof newly formed bone connected the edge of the implant to the wall
of themarrow cavity (Fig. 2(f)). A periosteal reaction [40,41] with corti-
cal hyperostosis was detectable over the outer left surface of the
80BG20HA section. In this case, several bone bridges came from the im-
plant edges (Fig. 2(g)). Finally, the 30BG70HA rod was well integrated
in the femur cortex. Someaspects of incomplete healingproduced irreg-
ularities of the outer cortex (i.e., empty spaces, see Fig. 2(h)).
3.3. Sham hole
The spontaneous bone healing of sham holes in rabbits, after
60 days, has been well described by the scientiﬁc literature [42], there-
fore the results dealing with the sham holes' healing have not been re-
ported here in detail. Brieﬂy, both the histology and the SEM
investigation demonstrated the new bone formationwithin the defects.
In particular, at the bone surface facing the bonemarrow cavity (i.e. the
endosteal surface), it was possible to note the difference in collagen
ﬁber orientation between native mature cortical bone and the newly
formed one. The thickness of the femur wall between the sham site
and the native diaphysis was constant. The SEM observation revealed
that the sham sites were typically rich in cells, while the Harvesian ca-
nals were clearly detectable. It was possible to distinguish between




As reported in Fig. 3(e, f), an intimate contact between newly formed
bone and grafted implant was clearly observed. The newly deposited
bone, in contactwith all surfaces of the implant, was rich in cells. Collagen
ﬁbers organization of newly formed bonewas parallel to the implant and
perpendicular to the lamellar native bone (Fig. 3(e)). No cracking and/or
fracture of the grafted implant were observed. The interface surface was
homogenous upon the grafted material, however some surface dissolu-
tionwas detectable at highermagniﬁcation at the implant/bone interface.
This ground glass aspect at the implant surface was ascribable to the for-
mation of a hydroxyapatite (HCA) layer, with an underneath silica-gel
like ﬁlm (sgl, see the following paragraphs), which is the condition for
achieving a stable bone tissue bonding (Fig. 3(e, f)) [21,24,43].
3.4.2. SEM
Bioactive bone-bonding mechanism is conﬁrmed by SEM micro-
graphs, reported in Figs. 3 and 4. The formation of an HCA layer on the
implant surface correspond to a light grey line in Fig. 3(a, b)). Newly
formed bone was clearly visible all around the implant. Some empty
spaces were detectable in the outer cortex, but not directly in contact
with the implant (Fig. 3(a)). It is possible to observe the typical organiza-
tion of collagen ﬁbers of younger bone tissue, which is more irregular
than that of native bone one (Fig. 3(b)). It should be noted the partial dis-
solution of 45S5 under the superﬁcial HCA layer at the bone/implant in-
terface (Fig. 3(b)). The bonding between implant and bone tissue was
particularly stable and not interspersedwith ﬁbrous tissue. A non-homo-
geneous bone healing from a morphological point of view occurred in
outer cortical layer of the femur mid-shaft, as some empty spaces were
present; nevertheless, a newly bone layer was in direct contact with
the implant by virtue of the material osteoconductivity (Fig. 3(a)). It
should be noted the presence of some cracks (see Figs. 3(a) and 4(a)).
The dissolution kinetics of the implant can be further analyzed by
taking into account the EDS maps, which show the distribution of Si, P
and Ca in the cross section of the implanted 45S5 (Fig. 7(a, e, i, o)). Si
is representative of 45S5, while P and Ca are present both in 45S5, in
HCA and in the bone. It should be noted a non-uniform dissolution of
the implant, which is characterized by areas with higher Si or Ca con-
tent. On the contrary, the distribution of P in the implant is rather uni-
form. At the interface between implant and bone it is possible to
Fig. 3. SEM and histological (Van Gieson/Stevene's blue stain) sections of 45S5 (a, b, e, f) and BG_Ca/Mix (c, d, g, h).
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the formation of HAC.
3.5. BG_Ca/Mix
3.5.1. Histology
Newly formed bone was in strict contact with the implant, without
any intervening ﬁbrous layer. The interface between bone and implantFig. 4. SEM sections of 45S5 (awas homogenous upon the grafted material, but extensive surface dis-
solution was detectable at higher magniﬁcation at the border of the im-
plant/bone interface (Fig. 3(g, h)). Indeed, the proﬁle between implant/
bone appeared quite irregular and undulated, and this fact can be as-
cribed to dissolution of the bioglass with concurrent formation of an
HCA layer and an underneath sgl ﬁlm, i.e. a layer rich in Si and poorer
in alkaline and alkaline earth ions with respect to the original glass.
This behaviour was similar to the 45S5 one, although the sgl layer in, c) and BG_Ca/Mix (b, d).
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(Fig. 3(e, g)). It should be noted that the formation of silica gel is report-
ed among the steps which lead to the conversion to HCA of the surface
of bioactive glasses [21] in physiological environment and, subsequent-
ly, to the formation of a bonding between implanted bioglass and bone.3.5.2. SEM
The implant showed good integration and high osteoconductivity,
even in the portion that overhanged in the marrow cavity (Fig. 3(c)).
The boundary between newly formed bone and native one is evident,
as well as the woven organization of the ﬁbers in the former
(Fig. 3(c)). It should be noted that the superﬁcial dissolution of the im-
plant, which is clearly visible, is more homogenous with respect to the
45S5-derived ceramic here investigated. In Fig. 3(d) it is possible to
note the formation of a HCA layer on the implant surface, which is ob-
servable as a light grey line, while the sgl ﬁlm is the dark grey band sur-
rounding the implant. The performance of BG_Ca/Mix in terms of
osteoconductivity has been further compared to that of 45S5 in the mi-
crographs of Fig. 4. In particular, in the BG_Ca/Mix sample (Fig. 4(d)) it
is possible to note the formation of a sort of newly formed “bony bridge”
which connects the implant and the native bone. Similar structures
were not observable in 45S5 samples (see Fig. 4(c)). Contrary to what
has been previously said about 45S5 implants, the SEM investigation
did not reveal the presence of cracks for BG_Ca/Mix samples. However,
it is possible to note some residual porosity in the specimens (Figs. 3(c,
d) and 4(b, d)).
The interface between BG_Ca/Mix implant and bone is investigated
at higher magniﬁcation in Fig. 5, where the results of the local chemical
analyses carried out by EDS are reported as well. Fig. 5(a) shows the
different regions of the bioactive glass that have reacted with blood
and bonded to bone: due to the ion exchange of K+, Na+ and Ca2+Fig. 5. The interface between bone and BG_Ca/Mix implant (a), and the 30BG70HA implantfrom the BG_Ca/Mix with H+ from the blood, a ﬁlm rich in Si and with
a lower content in alkaline and alkaline earth ions with respect to the
original glass forms at the surface of the implant (see Fig. 5(f), such
ﬁlm has been identiﬁed as sgl in the previous paragraph), with a HCA
ﬁlm (Fig. 5(e)) between this and the existing bone. In particular, new
bone tissue was formed and it is progressively growing into the de-
fect and into the marrow cavity area. This fact clearly indicates
osteoconduction. These ﬁndings are analogous to those reported in
ref. [44].
The EDS maps shown in Fig. 7(b, f, l, p) report an almost uniform
distribution of Si in the implant, apart from the bone/implant inter-
face, where it is possible to envisage the coexistence of HCA and sgl
areas. The bone tissue revealed the presence of Si traces, arising
from the dissolution of the adjoining glass. The almost uniform dis-
tribution of Ca along the cross section is indicative of the high Ca con-
tent in BG_Ca/Mix.3.6. 80BG20HA
3.6.1. Histology
The interface between the implant and the bonewas clear and linear
(see Fig. 6(e, f)). Newly deposited bone was in contact with the bioac-
tive glass and rich in cells. Several osseous lacunae were suggestive of
newly deposited bone and remodeling process. The refractive particle
related toHA granuleswere disposed in aggregate, both on the interface
and inside the implant (Fig. 6(e, f)). A layer related to the dissolution of
the glass phase, pink-purple colored in Fig. 6(e, f) was detected at the
surface of the implant. The edge between the newly deposited bone
and the native bone was clearly observable, as the bony lamellae were
parallel in the native trabecular bone, while woven bone is characteris-
tic of young newly deposited tissue adjacent to the implant (Fig. 6(e)).(b); (c–g): results of the EDS analysis performed on the areas reported in (a) and (b).
Fig. 6. SEM and histological (Van Gieson/Stevene's blue stain) sections of 80BG20HA (a, b, e, f) and 30BG70HA (c, d, g, h). The white arrow in (d) indicates an island of new formed bone
which developed around disaggregated micro-granules of 30BG70HA.
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SEM images, reported in Fig. 6(a, b) showed that the newly formed
bone tissue is in direct contact with the material; there are no empty
spaces, on the contrary the newly deposited bone began the static oste-
ogenesis starting from the implant material. The newly deposited bone
all around the rod surface, which was overhanged in the medullary
canal, documented an evident osteoconductive property of 80BG20HA
(Fig. 6(a)). Both the superﬁcial dissolution of the implant and the bioac-
tive bone-bonding mechanisms were evident: in this case, the HCA
layer which formed on the implant surface correspond to light grey
line in Fig. 6(b). Microcracking was visible at high magniﬁcation, but
never on the bone/implant interface (Fig. 6(b)). Finally, it should be
noted the presence of several light grey stripes of bone interspersed in
the dark grey newly formed bone, which documented an active bone re-
modeling with mineralization towards a lamellar bone tissue pattern
(Fig. 6(b)). The EDSmaps reported in Fig. 7(c, g, m, q) showed the pres-
ence of both HA- and Si-rich areas. While the latter can be mainly asso-
ciated to the glassy phase in 80BG20HA, the HA-rich areas, which
correspond to light grey areas in Fig. 7(c), are ascribable to the calcium
phosphate phase in the 80BG20HA composite and, to a lesser extent,
to the HCA which formed at the implant/bone interface.
3.7. 30BG70HA
3.7.1. Histology
The rod wasmechanically and partly disaggregated in particles dur-
ing the implantation and by the subsequent contact with physiological
ﬂuids (see Fig. 6(g, h)). Therefore, the interface between bone and ma-
terial wasmarkedly irregular and not linear, and the bone/implant con-
tact was somewhere discontinuous. Some granules of the composite
were dispersed in the area surrounding the implant. It should be
noted the presence of newly deposited bone around such 30BG70HA
particles.
3.7.2. SEM
SEMmicrographs, reported in Fig. 6(c, d) conﬁrmed the histological
ﬁndings. The material appeared to be highly fragmented in micro-granules and some of them were surrounded by new bone trabeculae
(white arrow, Fig. 6(d)). The bone/implant interface showed several
wide gaps, while newly formed bone islands were developed incorpo-
rating granules of BG30HA70. A distinct layer of newly formed bone
was present beyond disaggregated micro-granules and empty spaces
(see Fig. 6(d)). The porous structure of newly deposited bone, due to
higher cellular density, is visible; on the contrary, native mature bone
appeared in light grey due to higher mineralization. Newly formed
bonewas distinguishable all around the implant, however it was almost
impossible to identify a precipitated HCA-layer surrounding themateri-
al. The results of the EDS analysis, reported in Fig. 5(b, g), showed the
presence of Si, representative of the BG_Ca/Mix phase in the composite,
only in the inner part of the implant, i.e. the region that has been less af-
fected by the physiological ﬂuids. Elsewhere the glass phase of the com-
posite is almost dissolved. This fact is further conﬁrmed by the results of
the EDSmaps reported in Fig. 7(d, h, n, r), where it was difﬁcult to iden-
tify the presence of Si, representative of the glass, at the bone/implant
interface. The silicon traces are evenly spread both in the bone tissue
and in the composite, which is rather fragmented.
4. Discussion
Based on previous investigations, the novel BG_Ca/Mix looks partic-
ularly promising, with respect to thewidely used 45S5 Bioglass®, when-
ever a heat treatment is necessary for the production of speciﬁc systems
such as scaffolds or bioceramic composites. In fact, the main advantage
of BG_Ca/Mix is its low tendency to crystallize. Besides reducing the bio-
activity of the ﬁnal system, it is reported that crystallizationmay also in-
hibit or slow down the sintering process, so the higher thermal stability
of BG_Ca/Mix is expected to facilitate the production of fully dense bod-
ies starting from glass powders. As amatter of fact, BG_Ca/Mix powders
are able to consolidate at relatively low temperatures (about 800 °C), al-
most preserving the amorphous nature of the glass and its bioactivity
[25]. The same temperatures would be inadequate to sinter 45S5,
which has been reported to reach a full densiﬁcation only after thermal
treatments between 1050 °C and 1100 °C [45,46] which cause a wide
crystallization of the ﬁnal system with the formation of Na2Ca2Si3O9
and Na2CaSi2O6 phases [34,45,46].
Fig. 7. SEMmicrographs of the implantedmaterials' cross sections (a–d) and corresponding EDSmaps showing the distribution of Si (e–h), which is representative of the glass phase in the
produced materials, P (i–n) and Ca (o–r).
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ﬁbroblasts demonstrated the high osteoconductive potential of both
BG_Ca/Mix sintered powders and of HA/BG_Ca-Mix composites [28,
32]. Based on these encouraging results, it was conceivable that the pro-
duced materials could induce bone growth in vivo in an animal model.
In this sense, the rabbit femur is suitable for the in vivo evaluation of
osteoconduction of bioceramics [47].
The secondmotivation of the present study is to compare the perfor-
mances of BG_Ca/Mix and relatedHA-composites to 45S5 sintered pow-
ders, in order to identify possible advantages of the novel systems for
the realization of products that requires a consolidation of the starting
powders. In this sense, there is lack in the literature of works based on
animal model dealing on both 45S5 sintered powders and on HA-
based composites with silicate glasses as second phase, such as BG_Ca/
Mix.
Bone healing at the interface with the bone substitute was observ-
able for all the implants here studied, independently of the material
composition. In particular, the materials presented evidence of
osteoconduction. However, BG30HA70 looks rather different in terms
of performance: in fact, after 2 month of implantation, the implant
was rather disaggregated and newly deposited bone was not
homogenously organized, but often spread in islands around the HA,
which have not been reabsorbed. Integration partially occurred, never-
theless several visible non mineralized spaces between implant and
bone were specially detected by SEM. The spaces between BG30HA70granules were locally ﬁlled by new woven bone. Therefore, it is possi-
ble to conclude that BG30HA70 showed theminor bone regeneration
of the defect in comparisonwith remaining bone substitutes evaluat-
ed in the present study. This is mainly due to the high HA content of
BG30HA70. In fact, several Authors demonstrated that, although HA
is osteoconductive [20,48], HA implants have a slower bone apposi-
tion, integration and resorption compared to bioactive glasses and
glass-ceramics [49,50]. For example, implanted HA grafts are report-
ed to remain within the body for extended periods of time with no
signs of resorption [51]. The low reactivity and biodegradability in
physiological environment of HA is ascribable to its close similarity
between the mineral phase of bone. Therefore, it is not possible to
exclude that a further bone apposition and healing could occur for
BG30HA70 if implantation time would be longer. The disaggregation
of BG30HA70, which is mainly due to its residual porosity after
sintering [28], could be exploited in the future for the realization of
systems for controlled drug delivery.
45S5-derived glass-ceramics, BG_Ca/Mix and BG80HA20 were
surrounded by newly formed bone, in direct contact with the material
surface. Such materials did not show any intervening ﬁbrous tissue: this
aspect indicates good biocompatibilitywith consequent osseointegration.
The gradual surface dissolution of the implants did not produce signs of
inﬂammation at the interface between bone and material and it was not
observed any implant cracking, thus moving away from similar studies
based on animal models (see, for example, [47]). It is known that the
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nature of the interface [52]; in this sense, the osteoconduction ability of
45S5, BG_Ca/Mix and BG80HA20 was conﬁrmed by the formation of a
stable interface with the implant, which is characterized by the presence
of aHCAﬁlm. Suchﬁlmwas not observable in BG30HA70 samples, where
the newly deposited bone is distributed in discontinuous islands instead
of in an almost continuous layer.
Generally speaking, regarding the speciﬁc performance of the inves-
tigated materials in terms of osteoconduction, it is possible to observe
that BG_Ca/Mix samples were slightly higher osteoconductive than
45S5 derived glass ceramics, followed by BG80HA20 and BG30HA70. In
particular, both BG_Ca/Mix and 45S5 allowed the bone osteoconduction
over the rod surface that overhanged into the bone marrow cavity, but
the newly formed bony layer was more appreciable in BG_Ca/Mix sam-
ples (see Fig. 4). Moreover, although the apex of the rod that jutted out
into the bone marrow cavity was close to the endosteal surface both in
45S5 and in BG_Ca/Mix samples, nevertheless in BG_Ca/Mix the newly
formed bone connected the rod to the inner cortical bone, thus making
a sort of “bony bridge” between the graft and the bone tissue adjacent
to the bone marrow cavity (see Fig. 4(d)); it should be taken in mind
that in long bones, such as femurs, the bone marrow cavity is devoid of
bone. Similar “bony bridges” were not present in 45S5 samples. This
fact may be partly ascribed to the amorphous nature of BG_Ca/Mix,
while 45S5 – as previously discussed – is partially crystallized in re-
sponse to the thermal treatment which was employed to sinterize the
starting glass powders, and the biological performance of 45S5 is expect-
ed to be affected by such crystallization. In addition, several cracks were
observable in 45S5. In this context, it is reported by the literature that the
partial crystallization of the glass could lead to implant instability, since
the residual amorphous phase is degraded preferentially by organic
ﬂuids [24,53]. This fact could be conﬁrmed by the EDS maps here pre-
sented (Fig. 7), where 45S5 is characterized by the presence of areas
with higher Si or Ca content, thus indicating the potential non uniform
dissolution of the implant. It is important to note that in biomedical ap-
plications a non-uniform dissolution of the implant should be avoided,
since it can lead to the formation of non-uniform stresses along the
graft and to its pre-mature mechanical failure. In this context, no cracks
were observed, after 60 days of implantation, in the almost amorphous
BG_Ca/Mix.
5. Conclusions
In this work, for the ﬁrst time, a set of novel sintered bodies for bone
tissue repair have been tested in vivo in an animal model. The samples
were implanted bilaterally in themidshafts rabbit femurs and harvested
after 8 weeks. The recently developed BG_Ca/Mix bioactive glass and
two HA/BG_Ca-Mix composites with an increasing content of HA were
considered. In addition, 45S5 sintered powders were implanted and
used as a term of comparison. The preliminary ﬁndings reported in
the present study demonstrated the high osteoconductivity of BG_Ca/
Mix, which retained its amorphous nature despite thermal treatment
employed to sinterize the starting glass powders. The osteoconductive
ability of BG_Ca/Mix is slightly higher than that of 45S5 glass-ceramics,
followed by that of BG80HA20 and BG30HA70 samples. However, the
45S5 specimens after 8 weeks of implantation were locally cracked:
this fact may be ascribed to the partial crystallization of 45S5, as the re-
sidual glass phase was probably degraded preferentially by the physio-
logical ﬂuids. On the contrary such cracks, which could lead to implant
instability and unsuitable mechanical performance [24,53], were not
observed in BG_Ca/Mix. Morever, it should be noted that the densiﬁca-
tion of BG_Ca/Mix powders requires lower temperatures with respect
to 45S5, therefore such novel bioactive glass looks particularly promis-
ing also from an economical point of view, whenever a thermal treat-
ment is required for the production of speciﬁc systems, such as
scaffolds or composites. In this context, since the osteoconductivity of
BG80HA20 composites has been here demonstrated, it will beinteresting to investigate the in vivo biodegradation rate of such sys-
tems after longer implantation times and to further vary the volume
fractions of the two constituent phases, aiming to obtain systems with
degradation rate tailored for a given clinical application. Finally
BG30HA70, i.e. the composite richer in HA, looked fragmented after im-
plantation, with the formation of novel bone tissue adjacent to HA par-
ticles. In this sense, the disaggregation of BG_Ca/Mix composites with
an high content of HA could be exploited in the future for the realization
of systems for controlled drug delivery.Acknowledgments
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